PDCD10 and prostate cancer: Moreover, upregulation and the pro-survival/proliferative effects of PDCD10 were also demonstrated in non-small cell lung cancer (NSCLC), bladder cancer, ovarian cancer, cervical cancer, and prostate cancer [81,84,85,86,87,90,95,97,105].